Topic Hub
2 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 2 of 2 clinical reviews.
A complete drug-drug interaction table for PCSK9 inhibitors (evolocumab, alirocumab, inclisiran), plus class pharmacology, dosing, and prescribing guidance for FH and post-ACS patients.
Read clinical reviewA prescriber-level review of PCSK9 inhibitor use across special populations including familial hypercholesterolemia, post-ACS patients, chronic kidney disease, diabetes, elderly patients, and pregnancy, with dosing guidance and key trial data.
Read clinical review